U.S. Aesthetic Medicine Market Size and Growth
The U.S. aesthetic medicine market size was valued at USD 38.19 billion in 2023 and is anticipated to reach around USD 136.69 billion by 2033, growing at a CAGR of 13.6% from 2024 to 2033.
U.S. Aesthetic Medicine Market Key Takeaways
U.S. Aesthetic Medicine Market Growth
The surging societal focus on appearance is propelling the desire for aesthetic procedures, driving market growth. This shift in cultural norms, combined with the growing awareness of the diverse cosmetic solutions now accessible, has played a pivotal role in facilitating growth. Moreover, the growing acknowledgment & acceptance of various cosmetic interventions and the increasing geriatric population are other major factors expected to drive the demand for aesthetic medicines in the U.S.
Social media plays a vital role in influencing the purchasing decisions of millennials. However, peer recommendations have a significant impact. According to HubSpot statistics from 2019, around 71% of individuals are more inclined to buy a product or service online when others promote it. In addition, a few influencers control the majority of social media referral branding. Hence, ongoing client interaction is essential when a business advertises its products on social media.
Furthermore, a shift from invasive to minimally invasive procedures is being observed, which is expected to fuel market growth over the forecast period. According to the American Society of Aesthetic Plastic Surgeons (ASPS), in 2022, around 23,672,269 cosmetic minimally invasive procedures were performed in the U.S. Moreover, more people are opting for permanent procedures, such as fat grafting, fillers, and lip advancements. According to the same source, botulinum toxin & hyaluronic acid fillers, skin resurfacing, and laser skin treatments are some of the common & in-demand noninvasive aesthetic procedures in the U.S.
The most popular procedures are fillers, as the risk associated with these treatments is very low. Fillers such as hyaluronic acid, which are FDA-approved, are easily accepted by the body, causing minimal adverse effects & allergic reactions. The growing popularity of nonsurgical skincare treatment options is one of the primary factors responsible for an increase in the number of patients seeking plastic surgery services. Hence, the increased demand for nonsurgical cosmetic procedures can be attributed to the rising awareness of the risks & complications associated with invasive surgical procedures, such as delayed healing, incision scars, and adverse reactions to anesthesia. According to the American Society for Dermatologic Surgery (ASDS) 2019 report, specialists performed around 12.5 million cosmetic & medically necessary procedures in 2018, representing a 7.5% growth from 2017 and a 60% increase since 2012.
U.S. Aesthetic Medicine Market Report Scope
Report Attribute | Details |
Market Size in 2024 | USD 43.38 Billion |
Market Size by 2033 | USD 136.69 Billion |
Growth Rate From 2024 to 2033 | CAGR of 13.6% |
Base Year | 2023 |
Forecast Period | 2024 to 2033 |
Segments Covered | Procedure, age, metropolitan cities |
Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Key Companies Profiled | The Cosmetic Clinic; Therapie Clinic; SKINovative; Shea Aesthetic Clinic; Rejuv Medical; AnewSkin Medspa; R+H Medicine; Manhattan Aesthetics; SkinLab Clinic |
U.S. Aesthetic Medicine Market By Procedure Insights
The noninvasive procedures segment accounted for the largest market share of 54.22% in 2023. The growing popularity of noninvasive procedures can be attributed to several factors, including the demand for quick & easy treatments, the desire to avoid downtime, and the need for more natural-looking results. As consumer awareness continues to grow and technology continues to advance, the demand for noninvasive procedures is expected to remain strong. Moreover, in 2021, over 5.5 million nonsurgical cosmetic treatments, including toxin and fillers, were administered in the U.S. One of the most popular noninvasive procedures is Botox, which is used to reduce the appearance of wrinkles and fine lines. In 2021, over 4.4 million Botox procedures were performed, making it the most popular noninvasive procedure in the U.S. Other popular noninvasive procedures were soft tissue fillers, chemical peels, laser hair removal, and microdermabrasion.
The invasive procedures segment is expected to grow at a CAGR of 12.6% during the forecast period. Invasive procedures such as liposuction, breast augmentation, and nose reshaping are some of the popular aesthetic procedures. The growing focus on physical appearance has increased the demand for these invasive procedures. In the U.S. market, invasive procedures have become significantly popular since 2019, with the pandemic seemingly having little impact on the demand for these treatments. Liposuction, a procedure aimed at removing stubborn fat deposits, led the segment with a remarkable 325,669 procedures performed in 2022, representing a 23% increase since 2019. This suggests a growing acceptance and desire for body contouring procedures as individuals seek to achieve their desired physique.
U.S. Aesthetic Medicine Market By Age Insights
The 40 to 54 age segment accounted for the largest market share of 46.19% in 2023 and is expected to grow at the fastest CAGR of 13.9% during the forecast period. The rising number of people seeking treatments to maintain their youthful appearance and address aging concerns is driving growth. According to ASPS, in 2022, individuals aged 40 to 54 accounted for 44% of all liposuction procedures, 25% of forehead lifts, 20% of neck lifts, and a staggering 57% of all neuromodulator injections, such as Botox, Dysport, Xeomin, and Jeuveau.
This trend is driven by the desire for self-improvement, the growing acceptance of aesthetic procedures, and the influence of social media. Moreover, there has been a growing trend of nonsurgical body contouring treatments, such as CoolSculpting and EMsculpt, which are popular among individuals in this age group who want to improve their body shape without undergoing surgery.
U.S. Aesthetic Medicine Market By Metropolitan Cities Insights
Others segment accounted for the largest market share of 71.69% in 2023 and is expected to grow at the fastest CAGR of 13.8% during the forecast period .Indianapolis, Denver, and Columbus have a robust medical infrastructure, strong research base, and a high concentration of healthcare professionals. Moreover, these cities may have a higher demand for aesthetic procedures due to various factors, such as rapid population growth, increasing awareness, and a higher standard of living. Nashville, Oklahoma City, and Seattle in the Southwest are also emerging as significant cities in the aesthetic medicine market. Jacksonville, Florida, and San Jose, California, in the West, are also showing strong growth in demand for aesthetic medicine. These cities share common trends, such as an increase in healthcare expenditure, a growing number of dermatologists & aesthetic clinics, and a rising demand for aesthetic treatments, including nonsurgical face rejuvenation, body contouring, & skin resurfacing.
U.S. Aesthetic Medicine Market Recent Developments
Key U.S. Aesthetic Medicine Company Insights
Some of the key players operating in the market are the Cosmetic Clinic, Therapie Clinic, SKINovative, and Shea Aesthetic Clinic.
U.S. Aesthetic Medicine Market Top Key Companies:
U.S. Aesthetic Medicine Market Report Segmentation
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the U.S. Aesthetic Medicine market.
By Procedure
By Age
By Metropolitan Cities
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Procedure
1.2.2. Age
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. nova one advisor’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Procedure outlook
2.2.2. Age outlook
2.3. Competitive Insights
Chapter 3. Aesthetic Medicine Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Aesthetic Medicine Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Aesthetic Medicine Market: Procedure Estimates & Trend Analysis
4.1. Procedure Market Share, 2023 & 2033
4.2. Segment Dashboard
4.3. Aesthetic Medicine Market by Procedure Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
4.4.1. Invasive procedures
4.4.1.1. Market estimates and forecasts 2021 to 2033
4.4.1.2. Breast Augmentation
4.4.1.2.1. Market estimates and forecasts 2021 to 2033
4.4.1.3. Liposuction
4.4.1.3.1. Market estimates and forecasts 2021 to 2033
4.4.1.4. Nose Reshaping
4.4.1.4.1. Market estimates and forecasts 2021 to 2033
4.4.1.5. Eyelid Surgery
4.4.1.5.1. Market estimates and forecasts 2021 to 2033
4.4.1.6. Tummy tuck
4.4.1.6.1. Market estimates and forecasts 2021 to 2033
4.4.1.7. Others
4.4.1.7.1. Market estimates and forecasts 2021 to 2033
4.4.2. Non-invasive procedures
4.4.2.1. Market estimates and forecasts 2021 to 2033
4.4.2.2. Botox injections
4.4.2.2.1. Market estimates and forecasts 2021 to 2033
4.4.2.3. Soft tissue fillers
4.4.2.3.1. Market estimates and forecasts 2021 to 2033
4.4.2.4. Chemical peel
4.4.2.4.1. Market estimates and forecasts 2021 to 2033
4.4.2.5. Laser hair removal
4.4.2.5.1. Market estimates and forecasts 2021 to 2033
4.4.2.6. Microdermabrasion
4.4.2.6.1. Market estimates and forecasts 2021 to 2033
4.4.2.7. Others
4.4.2.7.1. Market estimates and forecasts 2021 to 2033
Chapter 5. Aesthetic Medicine Market: Age Estimates & Trend Analysis
5.1. Age Market Share, 2023 & 2033
5.2. Segment Dashboard
5.3. Aesthetic Medicine Market by Age Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
5.4.1. 19 and under
5.4.1.1. Market estimates and forecasts 2021 to 2033
5.4.2. 20-29
5.4.2.1. Market estimates and forecasts 2021 to 2033
5.4.3. 30-39
5.4.3.1. Market estimates and forecasts 2021 to 2033
5.4.4. 40-54
5.4.4.1. Market estimates and forecasts 2021 to 2033
5.4.5. 55-69
5.4.5.1. Market estimates and forecasts 2021 to 2033
5.4.6. 70+
5.4.6.1. Market estimates and forecasts 2021 to 2033
Chapter 6. Aesthetic Medicine Market: Metropolitan Cities Estimates & Trend Analysis
6.1. Metropolitan Cities Market Share, 2023 & 2033
6.2. Segment Dashboard
6.3. Aesthetic Medicine Market by Metropolitan Cities Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
6.4.1. New York
6.4.1.1. Market estimates and forecasts 2021 to 2033
6.4.2. Los Angeles
6.4.2.1. Market estimates and forecasts 2021 to 2033
6.4.3. Chicago
6.4.3.1. Market estimates and forecasts 2021 to 2033
6.4.4. Dallas
6.4.4.1. Market estimates and forecasts 2021 to 2033
6.4.5. Houston
6.4.5.1. Market estimates and forecasts 2021 to 2033
6.4.6. Washington
6.4.6.1. Market estimates and forecasts 2021 to 2033
6.4.7. Miami
6.4.7.1. Market estimates and forecasts 2021 to 2033
6.4.8. Philadelphia
6.4.8.1. Market estimates and forecasts 2021 to 2033
6.4.9. Atlanta
6.4.9.1. Market estimates and forecasts 2021 to 2033
6.4.10. Phoenix
6.4.10.1. Market estimates and forecasts 2021 to 2033
6.4.11. Others
6.4.11.1. Market estimates and forecasts 2021 to 2033
Chapter 7. Competitive Landscape
7.1. Company/Competition Categorization
7.2. Company Profiles
7.2.1. The Cosmetic Clinic
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Product benchmarking
7.2.1.4. Strategic initiatives
7.2.2. Therapie Clinic
7.2.2.1. Company overview
7.2.2.2. Financial performance
7.2.2.3. Product benchmarking
7.2.2.4. Strategic initiatives
7.2.3. SKINovative
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Product benchmarking
7.2.3.4. Strategic initiatives
7.2.4. Shea Aesthetic Clinic
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. Rejuv Medical
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. AnewSkin Medspa
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. R+H Medicine
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
7.2.8. Manhattan Aesthetics
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Product benchmarking
7.2.8.4. Strategic initiatives
7.2.9. SkinLab Clinic
7.2.9.1. Company overview
7.2.9.2. Financial performance
7.2.9.3. Product benchmarking
7.2.9.4. Strategic initiatives